-
Audit of Check4Cancer’s One Stop Breast Clinic network confirms clinical excellence in the private sector
Jul 14, 2020, 05:19 AM by Michael CroftCAMBRIDGE, UK - Jul 14, 2020 - Cambridge, UK, 14th July 2020 / Sciad Newswire / Check4Cancer, the reliable and trusted provider of early cancer detection and genetic services in the UK, announces audit results from its private breast cancer diagnostic pathway, confirming Check4Cancer's One Stop Breast Clinic network provides clinical excellence for patients experiencing symptoms of breast cancerFull story -
Elucid Digital Health’s dashboard gives pharma and CROs real time patient adherence data during a clinical trial
Jul 13, 2020, 10:46 AM by Michael CroftMANCHESTER, UNITED KINGDOM - Jul 13, 2020 - Elucids Pill Connect dispensing system provides CROs and pharma the ability to show adherence across the whole trial, by country, by site even down to the individual patient number in real timeFull story -
Creative Proteomics Launches Untargeted Metabolomics Services for Drug Development
Jul 13, 2020, 04:36 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 13, 2020 - Creative Proteomics, an integrated CRO company that provides a full range of drug development services, has recently launched its fully-developed untargeted metabolomics services to researchersFull story -
CD Genomics Announces MicroCollect™ FDA&CE Certificated Virus Collection Swab Kits for SARS-CoV-2 Detection
Jul 13, 2020, 04:31 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 13, 2020 - CD Genomics, an internationally leading provider of microbial testing services, microbial genomics services, and integrated bioinformatics services for hospitals, food, diagnostics, pharma, agriculture, biotechnology, and research institutes, announces advanced virus collection kit for SARS-CoV-2 detectionFull story -
Creative Enzymes Optimizes Enzyme Stabilization and Formulation Services
Jul 13, 2020, 04:27 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Jul 13, 2020 - As an excellent supplier and manufacturer, Creative Enzymes has recently optimized enzyme stabilization and formulation services for researchers working in the life science fieldFull story -
Illumina Launches TruSight Software Suite, Accelerating Identification of Genetic Diseases
Jul 10, 2020, 10:05 AM by Michael CroftFull storyBio-IT World News Brief | Illumina, in collaboration with Mayo Clinic and other key opinion leaders, has launched its TruSight Software Suite in an effort to bring turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing.
-
Study Says Prior Infection Could Prevent Reinfection, Other COVID-19 News
Jul 10, 2020, 08:35 AM by Michael CroftFull storyBio-IT World | Animal models are showing how prior infection of the SARS-CoV-2 virus can provide protection against reinfection. Elsewhere, a coronavirus task force task force is examining genes associated with COVID-19 immune response by collecting samples from Japanese patients. This, plus more, are featured in this week’s COVID-19 news from the biotech and research industries.
-
Wearable, Wireless Biometric Sensor Devices from Shimmer Provide Much-Needed Patient Data in Battle Against COVID-19
Jul 9, 2020, 14:57 PM by Michael CroftCAMBRIDGE, MA, UNITED STATES - Jul 9, 2020 - Shimmer, a leading provider of wearable wireless sensor products and solutions, has partnered with the University of South Florida to develop an early warning system, including a wearable device, to help detect the progression of COVID-19 for those most at risk of severe infectionFull story -
TrialScope Expands Leadership Team with New Chief Commercial Officer
Jul 9, 2020, 11:22 AM by Michael CroftJERSEY CITY, NJ, UNITED STATES - Jul 9, 2020 - TrialScope, the global leader in clinical trial transparency, has hired Chris Venezia as Chief Commercial Officer, expanding its executive teamFull story -
Virtual Twins: Their Roles In Healthcare, Drug Discovery, And Pandemic Response
Jul 9, 2020, 10:10 AM by Michael CroftFull storyBio-IT World | In a world that has shifted to virtual everything—work, recreation, connection—it’s no wonder that virtual or digital twins are getting more attention. It’s certainly a favorite term of marketers: we are creating digital twins for everything from people to businesses, instruments to labs.
-
HENRY SCHEIN MEDICAL ANNOUNCES EXPANSION OF MEDPOD’S TELEMEDICINE SOLUTIONS WITH INTEGRATION OF VISUALDX
Jul 9, 2020, 10:02 AM by Michael CroftMELVILLE, NY, UNITED STATES - Jul 9, 2020 - Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. and exclusive distributor of Medpod, IncFull story -
SCL Health Partners with Kyruus to Enhance Consumer and Provider Experience
Jul 8, 2020, 11:17 AM by Michael CroftBOSTON, MA, UNITED STATES - Jul 8, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, and SCL Health, a faith-based nonprofit health system providing care across Colorado, Kansas, and Montana, today announced that SCL Health has selected Kyruus patient access and provider data management platform to enable its digital access initiativesFull story -
Absolute Antibody and University of Zurich Collaborate to Offer Synthetic Nanobodies Against SARS-CoV-2 Receptor Binding Domain
Jul 8, 2020, 09:53 AM by Michael CroftREDCAR, UNITED KINGDOM - Jul 8, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with University of Zurich to offer synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2, the coronavirus that causes COVID-19Full story -
Can Your Data Protection Strategy Survive A Pandemic?
Jul 8, 2020, 08:15 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Across the world, scientific laboratories have redirected their research efforts toward the global COVID-19 pandemic. Achieving the goal of understanding and treating the virus requires the generating and gathering of data. Like any big shift in the way we generate, manage, or use data, this will have implications for the datacenter.
-
Optibrium and North Carolina School of Science and Mathematics mark five years of education collaboration with summer school ‘Computing COVID-19’
Jul 8, 2020, 06:01 AM by Michael CroftCAMBRIDGE, UK AND DURHAM, NC, USA, UNITED KINGDOM - Jul 8, 2020 - Optibrium, a leading provider of software and services for drug discovery, and the North Carolina School of Science and Mathematics (NCSSM), the states leading high school for science, technology and math education, are celebrating five years of an education support collaborationFull story -
Boehringer Ingelheim Extends TrialScope Partnership
Jul 7, 2020, 12:05 PM by Michael CroftJERSEY CITY, NJ, UNITED STATES - Jul 7, 2020 - In its ongoing commitment to maintaining compliance with ever-changing global clinical trial disclosure regulations, Boehringer Ingelheim has renewed its partnership with TrialScope for an additional five yearsFull story -
InSysBio to announce the launch of its new tool Heta compiler
Jul 7, 2020, 05:04 AM by Michael CroftMOSCOW, RUSSIA - Jul 6, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platformsFull story -
OPTRONICS Releases New Visual Inspection Tools Now Available on GSA Contract.
Jul 6, 2020, 17:12 PM by Michael CroftGOLETA, CA, UNITED STATES - Jul 6, 2020 - FOR IMMEDIATE RELEASEFull story
OPTRONICS Releases New Visual Inspection Tools Now Available on GSA Contract -
Bio-IT World Announces 2020 Innovative Practices Award Winners
Jul 6, 2020, 09:00 AM by Michael CroftFull storyBio-IT World | Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance have been announced as the winners of the 2020 Innovative Practices Awards.
-
How The SARS-CoV-19 Virus Attacks Cells, Other COVID-19 News
Jul 2, 2020, 08:25 AM by Michael CroftFull storyBio-IT World | New research shows how the SARS-CoV-19 virus shifts the cell's activity to promote its own replication and to infect nearby cells. This, plus more, are featured in this week’s COVID-19 news from the biotech and research industries.